Estimated reading time: 1 minute, 18 seconds

KPMG: Pharma/Biotech Investment Booming

Venture capital investments in the economy’s pharma and biotech sector is booming, according to Venture Pulse, a quarterly report published by KPMG Private Enterprise. Globally, VC investment has risen for the second straight quarter, although more money went into far fewer deals.

Total VC investment reached $73.2 billion in the third quarter with pharma and biotech drawing $31 billion of that. That was up from $70 billion in the second quarter, but the number of deals dropped to 4,681 from 5,674 the sixth straight quarter of decline and the lowest total since the fourth quarter of 2013. 

The United States had $37.8 billion in investment, out of $40 billion in the Americas for the quarter. VC investment in Asia-Pacific was $21.1 million in the quarter, up from $17.2 billion in the second quarter. Investment in Europe in $12.1 billion, which the publication describe as a new high.

Bob Scott
Bob Scott has provided information to the tax and accounting community since 1991, first as technology editor of Accounting Today, and from 1997 through 2009 as editor of its sister publication, Accounting Technology. He is known throughout the industry for his depth of knowledge and for his high journalistic standards.  Scott has made frequent appearances as a speaker, moderator and panelist and events serving tax and accounting professionals. He  has a strong background in computer journalism as an editor with two former trade publications, Computer+Software News and MIS Week and spent several years with weekly and daily newspapers in Morris County New Jersey prior to that.  A graduate of Indiana University with a degree in journalism, Bob is a native of Madison, Ind
Read 359 times
Rate this item
(0 votes)

Visit other PMG Sites:

click me
PMG360 is committed to protecting the privacy of the personal data we collect from our subscribers/agents/customers/exhibitors and sponsors. On May 25th, the European's GDPR policy will be enforced. Nothing is changing about your current settings or how your information is processed, however, we have made a few changes. We have updated our Privacy Policy and Cookie Policy to make it easier for you to understand what information we collect, how and why we collect it.